Role of angiotensin II in extracellular matrix and transforming growth factor-β1 expression in hypertensive rats
The in vivo effects of alacepril (1-[(S)-3-acetylthio-2-methylpropanoyl]- L-prolyl- L-phenylalanine), an angiotensin converting enzyme inhibitor, and SC-52458 (5-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]-2-[2-(1H-tetrazol-5-ylphenyl)]pyridine), an angiotensin AT 1 receptor antagonist, were examine...
Saved in:
Published in | European journal of pharmacology. Molecular pharmacology section Vol. 269; no. 1; pp. 115 - 119 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Amsterdam
Elsevier B.V
01.09.1994
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The in vivo effects of alacepril (1-[(S)-3-acetylthio-2-methylpropanoyl]-
L-prolyl-
L-phenylalanine), an angiotensin converting enzyme inhibitor, and SC-52458 (5-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]-2-[2-(1H-tetrazol-5-ylphenyl)]pyridine), an angiotensin AT
1 receptor antagonist, were examined on the cardiac and aortic gene expressions of extracellular matrices and TGF-β1 in young spontaneously hypertensive rats (SHR). In SHR, types I and III collagen mRNAs were increased in the left ventricle, and in contrast, fibronectin, collagen IV, and transforming growth factor-β1 (TGF-β1) mRNAs were increased in aorta, compared with those in Wistar-Kyoto rats. All the enhanced mRNAs in both organs in SHR were significantly inhibited by the short-term treatment with the above two drugs. Thus, angiotensin AT
1 receptor may play an important role in the regulation of extracellular matrices and TGF-β1 expressions in SHR. |
---|---|
ISSN: | 0922-4106 |
DOI: | 10.1016/0922-4106(94)90033-7 |